CTDNEP1–NEP1R1 Control of ER Lipid Homeostasis
2026-08-12
This study shows that CTDNEP1 relies on NEP1R1 to remain stable and restrict endoplasmic reticulum expansion, whereas CTDNEP1 can limit lipid droplet formation without this regulatory subunit. By combining structure–function analysis, biochemical assays, modeling, and quantitative cell imaging, the authors establish that CTDNEP1 regulation is tailored to the distinct demands of membrane synthesis and lipid storage.
SIRT1–PGC-1α–TFAM Protection in Prion-Stressed N2a
2026-08-11
Zhao et al. identify a SIRT1-dependent PGC-1α–TFAM pathway that restores mitochondrial biogenesis and reduces mitochondrial injury and apoptosis in PrP106–126-treated N2a cells. The study positions resveratrol as a pharmacological SIRT1 activator for mechanistic neuroprotection studies, while emphasizing the need for validation beyond this peptide-based cellular model.
Disodium Bicinchoninate in Cardiac Fibrosis Assays
2026-08-10
Disodium bicinchoninate supports aqueous assay development for protein normalization and metal-responsive biochemical workflows without a DMSO or ethanol vehicle. Its practical value is especially clear when profiling high-glucose cardiomyocyte–fibroblast models linked to the cGMP/PKG pathway, provided the reagent is validated for the intended assay chemistry.
Mitochondrial Permeability Transition Pore Assay Kit
2026-08-09
Discover how the Mitochondrial Permeability Transition Pore Assay Kit connects pore opening with ROS-driven mitochondrial injury and intrinsic apoptosis. This guide focuses on mechanistic interpretation, assay controls, and evidence-based decisions for cell death research.
Dlin-MC3-DMA: Practical LNP RNA Delivery Guide
2026-08-08
Dlin-MC3-DMA is an ionizable cationic liposome lipid for building reproducible LNPs that carry siRNA or mRNA into cells. This guide connects formulation setup, hepatic gene silencing, mRNA vaccine formulation, assay controls, and troubleshooting with machine-learning insights from a published reference study.
G007-LK Tankyrase 1/2 Inhibitor Guide
2026-08-07
G007-LK is a selective tankyrase 1/2 inhibitor for mechanistic studies of Wnt/β-catenin signaling, Hippo-YAP regulation, and cancer biology. Biochemical, cellular, and xenograft data support its use in APC mutation colorectal cancer research and related preclinical models, but the compound remains a research tool rather than a clinical treatment.
Ginsenoside Rg1 Restores Gut-Immune-Brain Axis After Anesthe
2026-08-07
The reference study demonstrates that Ginsenoside Rg1, a triterpene saponin from Panax ginseng, reverses neuroimmune disruptions and cognitive deficits caused by prolonged isoflurane anesthesia in mice. The findings provide direct evidence for Treg-mediated gut-immune-brain axis restoration as a novel strategy for neuroprotection in perioperative and neurodegenerative research.
EMD638683: SGK1 Inhibition for Vascular and Cancer Research
2026-08-06
Explore the strategic role of EMD638683, a selective SGK1 inhibitor, in unraveling the mechanisms of vascular stiffening and cancer progression. Grounded in recent mechanistic evidence and translational models, this article provides actionable insights for researchers leveraging SGK1 inhibition in high-impact disease workflows.
2-NBDG: Transforming Glucose Uptake Assays in Cancer Researc
2026-08-06
2-NBDG, a fluorescent glucose analog, empowers researchers to quantify cellular glucose uptake with unmatched sensitivity and versatility across cancer and metabolic disease models. Discover optimized workflows, troubleshooting insights, and the latest protocol enhancements that make 2-NBDG the gold standard for dynamic glucose metabolism assays.
Hexamethonium Bromide: Mechanistic Dissection of Autonomic C
2026-08-05
Explore how Hexamethonium Bromide, a selective antagonist of neuronal-type nicotinic AChR, enables mechanistic insights into autonomic ganglia function and sex-specific hypertension research. This article uniquely bridges granular pharmacology with experimental strategy for advanced neuronal signaling investigations.
Evaluating Drug Responses in Cancer: Insights from Advanced
2026-08-05
Schwartz's dissertation presents a rigorous analysis of in vitro methods for distinguishing between drug-induced cell death and growth inhibition in cancer research. By clarifying the differential measurement of relative and fractional viability, the study provides a framework for more precise evaluation of anticancer agents and their mechanistic effects.
SIRT1 Regulates Centriole Duplication via Plk2 Deacetylation
2026-08-04
The referenced study uncovers the role of SIRT1 in controlling centriole duplication by targeting the centrosome protein Plk2 for deacetylation and subsequent degradation. This mechanistic insight links acetylation status to centrosome homeostasis, with implications for understanding chromosomal instability in cancer.
Cdk1–PP2A Phospho-Switch Orchestrates Atypical E2F Degradati
2026-08-04
This study reveals how coordinated phosphorylation by Cdk1 and dephosphorylation by PP2A constitute a molecular switch regulating the timely proteolysis of atypical E2F transcription factors during the cell cycle. The work advances understanding of protein phosphorylation analysis in cell cycle control, with implications for dissecting regulatory protein turnover.
Apicidin Impairs Oocyte Maturation via Meiotic and Epigeneti
2026-08-03
A recent study reveals that Apicidin, a selective histone deacetylase inhibitor and emerging mycotoxin, compromises oocyte quality by disrupting the meiotic apparatus and altering histone acetylation. These findings provide new mechanistic insights into reproductive toxicity and raise concerns for food safety and experimental design in epigenetics research.
XXLP Targets NOX2/ROS/Mitochondria/NLRP3 Axis in Ulcerative
2026-08-03
Xu Chunfu’s Modified Xianglian Pill (XXLP) demonstrates a novel ability to attenuate ulcerative colitis via modulation of the NOX2/ROS/mitochondria/NLRP3 axis and restoration of gut microbiota balance. This integrated approach highlights potential avenues for improved therapeutic strategies and mechanistic research in colitis and related inflammatory disorders.
507 records 12/34 page Previous Next First page 上5页 1112131415 下5页 Last page